Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

FDA Puts Clinical Holds on Trials of BPX-501

January 31st 2018

The FDA has halted 4 US studies of BPX-501, a novel cellular immunotherapy for cancers and orphan inherited blood disorders, after 3 patients developed encephalopathy possibly related to treatment with BPX-501.

Dr. Wang Discusses Crenolanib Plus Chemotherapy in AML

January 30th 2018

Eunice Wang, MD, chief, Leukemia Service, professor of Oncology, Departments of Medicine and Immunology, Roswell Park Cancer Institute, discusses the combination of crenolanib and cytarabine/anthracycline chemotherapy in patients with acute myeloid leukemia.

Dr. Skarbnik on Impact of Checkpoint Inhibition Following ASCT

January 30th 2018

Alan Skarbnik, MD, staff physician, department of Bone Marrow Transplant, department of Lymphoma, John Theurer Cancer Center, discusses the preliminary safety and efficacy data for checkpoint inhibition with ipilimumab (Yervoy) and nivolumab (Opdivo) following autologous stem cell transplantation in high-risk hematologic malignancies.

Acute Lymphoblastic Leukemia: The Future of Treatment

January 30th 2018

Role of CAR T-Cell Therapy in Relapsed/Refractory ALL

January 30th 2018

Relapsed/Refractory ALL: Inotuzumab Ozogamicin

January 30th 2018

Relapsed/Refractory ALL: Evaluating Novel Agents

January 30th 2018

Approaching Treatment for Relapsed/Refractory ALL

January 30th 2018

MRD-Positive ALL: Personal Approaches to Treatment

January 30th 2018

ALL: Therapy for Post-Induction MRD-Positivity

January 30th 2018

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

January 30th 2018

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

January 30th 2018

MRD Testing in ALL: Sensitivity and Availability

January 30th 2018

Importance of MRD Testing in Acute Lymphoblastic Leukemia

January 30th 2018

Optimizing Allogeneic Transplant Strategies in ALL

January 30th 2018

Up-front Approaches to Treating Ph-Negative ALL

January 30th 2018

Defining Ponatinib's Role in Ph-Positive ALL

January 30th 2018

Philadelphia Chromosome-Positive ALL: Upfront Approaches

January 30th 2018

T-Cell Acute Lymphoblastic Leukemia: Impacting Prognosis

January 30th 2018

Acute Lymphoblastic Leukemia: Risk Stratification

January 30th 2018